INTRODUCTION
============

Commonly acknowledged, inflammation plays important roles in the initiation and progress of many diseases including cancer in multiple organ sites ([@b1-pnf_2013_v18n1_23]). Inflammation, classified either as acute or chronic, has been described as the basis of many human diseases. Acute inflammation occurs from minutes to hours and days following tissue damage caused by physical force or an immune response. Chronic inflammation occurs over a longer period of time and is caused by pro-inflammatory mediators. Chronic inflammation in linked to rheumatoid arthritis, diabetes, atherosclerosis, and cancer ([@b2-pnf_2013_v18n1_23]--[@b4-pnf_2013_v18n1_23]). Therefore, inhibition of the production of pro-inflammatory mediators is an important goal in the treatment of various inflammatory diseases.

The lipopolysaccharides (LPS)-treated Raw 264.7 cells have been widely used to study inflammatory responses. Exposure of Raw 264.7 cells to external bacterial toxins like LPS has been extensively shown to stimulate the secretion of nitric oxide (NO), which is produced by the inducible isoforms of nitric oxide synthase ([@b5-pnf_2013_v18n1_23]). When the body is stimulated by pathologic injury, activated macro phages release numerous pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α, and inflammatory mediators, such as NO, inducible NOS (iNOS) and cycloocygenase-2 (COX-2) ([@b6-pnf_2013_v18n1_23]). COX-2 can convert arachidonic acid to prostaglandin and other eicosanoids. Aberrant functioning of COX-2 has been associated with carcinogenesis by promoting cell survival, angiogenesis, and metastasis ([@b7-pnf_2013_v18n1_23]--[@b9-pnf_2013_v18n1_23]). NO is generated enzymatically by synthases (NOS) and is formed by iNOS in macrophages and other cells that play a role in the inflammatory response. Enormous amounts of NO can stimulate many proteins and enzymes crucial to inflammatory reactions, such as nuclear factor-kappa B (NF-κB) ([@b10-pnf_2013_v18n1_23]). Therefore, various cytokines, NO, iNOS and COX-2 are important targets for anti-inflammation remedy.

Approximately 40,000 tons of oysters are annually harvested in Korea. Oyster shells, more than 90% of the oyster content, was wasted and has recently induced a serious environmental pollution ([@b11-pnf_2013_v18n1_23]). However, oyster shells contain a large amount of calcium carbonate (CaCO~3~), and relatively low amounts of calcium sulfate (CaSO~4~), calcium phosphate (CaPO~4~), and amino acids ([@b12-pnf_2013_v18n1_23]). Oyster shells are one of the most famous traditional antacid medicines in China, Japan and Korea. According to Bonchogangmok, oyster shells were used to medicine dermatitis. Recently, oyster shells are used as a substitute for calcium agents. However, no scientific proof or reports exist on the potential anti-inflammatory activity of oyster shells. Thus, this study examined the effect of oyster shell extract on antioxidant activities and anti-inflammatory response in LPS-stimulated Raw 264.7 cells.

MATERIALS AND METHODS
=====================

Preparation of oyster shell extract
-----------------------------------

Oyster shell was collected from the Duckyen company in Tongyeong, South Korea. Salt, sand and epiphytes were removed using tap water. The samples were rinsed carefully with fresh water and air-dried. Dried oyster shell was ground and sifted through a 800 mesh. Ground oyster shell was extracted with 0.5 M citrate in water at 30°C for 12 h and centrifuged at 8,000 rpm at 4°C. After centrifuging for 20 min, the supernatant liquid was collected and filtered through an ultrafiltration system (QuixStand Benchtop, GE Healthcare, Piscataway, NJ, USA) at 15 psi and 100 rpm by hollow fiber membranes with molecular weight cut-off values of 10 kDa. Filtered liquid was vacuum-dried and the powder was stored at −80°C.

Cell culture and treatment
--------------------------

Mouse macrophage Raw 264.7 cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL of penicillin and 100 μg/mL of streptomycin at 37°C in 5% CO~2~/95% air. Cells in 96 well plates (2×10^4^ cells/well) were treated with oyster shell extract (10, 25, 50, 100 μg/mL) for 2 h, and then incubated with LPS (1 μg/mL) for 20 h.

Cell viability
--------------

Cell viability was assessed using a modified 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay ([@b13-pnf_2013_v18n1_23]). Briefly, cells (2×10^4^ cells/well) were seeded in a 96 well plate and treated oyster shell extract. Following treatment, 100 μL of MTT solution (5 mg/mL in phosphate buffered saline) was added to each well and further incubated for 4 h at 37°C. Subsequently, 100 μL of dimethyl sulfoxide (DMSO) was added to each well to dissolve any deposited formazan. The optical density (OD) of each well was measured at 540 nm with a microplate reader (Bio-Rad Laboratories Inc., Hercules, CA, USA).

Measurements of intracellular ROS level
---------------------------------------

Intracellular ROS levels were measured by the 2',7'-dichlorofluorescein diacetate (DCF-DA) assay ([@b14-pnf_2013_v18n1_23]). DCF-DA can be deacetylated in cells, where it can react quantitatively with intracellular radicals to convert into its fluorescent product, DCF, which is retained within the cells. Therefore, DCF-DA was used to evaluate the generation of ROS in oxidative stress. Thereafter, the medium was removed and the cells were washed twice with phosphate buffered saline (PBS, pH 7.4) and incubated with 5 μL DCF-DA for 30 min at room temperature. Fluorescence was measured using a fluorescence plate reader (BMG LABTECH GmbH, Offenberg, Germany).

Measurement of antioxidant enzyme activities
--------------------------------------------

Cells (2×10^4^ cells/well) in a 96 well plate were pre-incubated with various concentrations (10, 25, 50, and 100 μg/mL) of oyster shell extract for 2 h, then further incubated with LPS for 20 h. The medium was removed and the cells were washed twice with PBS. 1 mL of 50 mmol/L potassium phosphate buffer with 1 mmol/L EDTA (pH 7.0) was added and the cells were scraped. Cell suspensions were sonicated three times for 5 sec on ice each time then centrifuged at 10,000×*g* for 20 min at 4°C. Cell supernatants were used for measuring anti-oxidant enzyme activities. The protein concentration was measured by using the Bradford method ([@b15-pnf_2013_v18n1_23]) with bovine serum albumin as the standard. Superoxide dismutase (SOD) activity was determined by monitoring the auto-oxidation of pyrogallol. A unit of SOD activity was defined as the amount of enzyme that inhibited the rate of oxidation of pyrogallol. Catalase activity was measured according to method of Aebi ([@b16-pnf_2013_v18n1_23]) by following the decreased absorbance of H~2~O~2~. The decrease of absorbance at 240 nm was measured for 2 min. Standards containing 0, 0.2, 0.5, 1 and 2 mmol/L of H~2~O~2~ were used for the standard curve. Glutathione peroxidase (GSH-px) activity was measured by using the method of Lawrence and Burk ([@b17-pnf_2013_v18n1_23]). One unit of GSH-px was defined as the amount of enzyme that oxidized 1 nmol of NADPH consumed per minute.

Measurement of NO level
-----------------------

Each 50 μL of culture supernatant was mixed with an equal volume of Griess reagent \[0.1% N-(1-naphthyl)-ethylenediamine, 1% sulfanilamide in 5% phosphoric acid\] and incubated at room temperature for 10 min, The absorbance at 550 nm was measured in a microplate absorbance reader (Bio-Rad Laboratories Inc.) and a series of known concentrations of sodium nitrite were used as the standards ([@b18-pnf_2013_v18n1_23]).

Western blotting
----------------

TNF-α, IL-1β, IL-6, iNOS and COX-2 expressions and NF-κB DNA binding activity were determined by western blot analysis. Total protein for TNF-α, IL-1β, IL-6, iNOS, COX-2 and nuclear protein for NF-κB were electrophoresed through 10% sodium dodecyl sulfate-polyacrylamide gel. Separated proteins were transferred electrophoretically to a pure nitrocellulose membrane, blocked with 5% skim milk solution for 1 h, and then incubated with primary antibodies overnight at 4°C ([@b19-pnf_2013_v18n1_23]). After washing of the blots, they were incubated with goat anti-rabbit or goat anti-mouse IgG HRP conjugated secondary antibody for 1 h at room temperature. Each antigen-antibody (Abcam, Cambridge, UK) complex was visualized using ECL western blotting detection reagents and detected by chemiluminescence with LAS-1000 plus. Band densities were determined by an image analyzer ATTO densitograph and normalized to β-actin for total protein and nuclear protein.

Statistical analysis
--------------------

The data were represented as mean±SD. The statistical analysis was performed using SAS software (SAS Institute Inc., Cary, NC, USA). The values were evaluated by one-way analysis of variance (ANOVA) followed by post-hoc Duncan's multiple range tests.

RESULTS AND DISCUSSION
======================

Cell viability
--------------

Raw 264.7 cells viability in the presence of oyster shell extract is shown in [Fig. 1](#f1-pnf_2013_v18n1_23){ref-type="fig"}. These data indicate that oyster shell extract does not effect the viability of Raw 264.7 cells at the concentrations of 0\~1,000 μg/mL.

Intracellular ROS generation
----------------------------

ROS are known to be crucial inflammatory mediators. During an inflammatory response, the excessive production of ROS can cause major damage to cells, which can lead to DNA damage and mutations ([@b20-pnf_2013_v18n1_23],[@b21-pnf_2013_v18n1_23]). High ROS levels induce oxidative stress and inflammatory reactions, which can result in a variety of biochemical and physiological lesions ([@b22-pnf_2013_v18n1_23]). The effects of oyster shell extract on ROS production in LPS-stimulated Raw 264.7 cells is shown in [Fig. 2](#f2-pnf_2013_v18n1_23){ref-type="fig"}. LPS significantly increase (p\< 0.05) ROS generation in Raw 264.7 cells. However, oyster shell extract significantly reduced (p\<0.05) LPS-generated ROS in a dose-dependent manner. Oyster shell extract at concentrations of 10, 25, 50 and 100 μg/mL reduced the intracellular ROS levels to 135.40%, 133.58%, 121.06%, and 107.75%, respectively. Oyster shell extract might effectively prevent inflammation by decreasing ROS production.

Antioxidant enzyme activities
-----------------------------

Several antioxidant enzymes such as SOD, GSH-px, and catalase provide eukaryotic cells with a primary defense against ROS. This antioxidant defense becomes particularly important to phagocytes as macrophages are able to generate very high concentrations of ROS ([@b23-pnf_2013_v18n1_23]). [Table 1](#t1-pnf_2013_v18n1_23){ref-type="table"} shows antioxidant enzyme activities of oyster shell extract in LPS-stimulated Raw 264.7 cells. The activity of SOD was decreased by LPS and significantly recovered (p\<0.05) by oyster shell extract, with values from 45.83±2.56, 51.14±0.94, 63.89±2.63 and 65.74±1.14 μM/mg protein (10, 25, 50 and 100 μg/mL oyster shell extract, respectively). SOD is an enzyme that has anti-inflammatory capacity because of its ability to scavenge the superoxide free-radical ([@b24-pnf_2013_v18n1_23]). SOD catalyzes the dismutation of superoxide radicals to oxygen and hydrogen peroxide (H~2~O~2~). H~2~O~2~ is further reduced to H~2~O by the activity of catalase or glutathione peroxidase. SOD may increase hydrogen peroxide that sometimes plays a role as a second messenger in the production of inflammatory cytokines including TNF-α, IL-1β, and IL-6 ([@b25-pnf_2013_v18n1_23]). Catalase activities were significantly increased (p\< 0.05) by oyster shell extract treatment from 1.24±0.01 to 1.56±0.01 μM/mg protein, with the addition of 10 μg/mL oyster shell extract. Recent studies have shown that *in vivo* or *in vitro* treatments of antioxidant enzymes, such as catalase or superoxide dismutase, are effective in reducing inflammation and cancer ([@b26-pnf_2013_v18n1_23],[@b27-pnf_2013_v18n1_23]). Glutathione acts as an oxy radical scavenger by scavenging NO and other oxidants, thereby protecting cells against oxidative damage by reducing oxidants ([@b28-pnf_2013_v18n1_23]). GSH-px is a family of intracellular antioxidant enzymes that reduce H~2~O~2~ and organic hydroperoxides by oxidizing glutathione; these enzymes play critical protective roles in the detoxification of ROS produced during inflammation ([@b29-pnf_2013_v18n1_23]). In this experiment, the GSH-px activity in the Raw 264.7 cells showed a significant increase (p\<0.05) upon treatment with oyster shell extract at 10, 25, 50 and 100 μg/mL, resulting in 3.41±0.04, 4.25±0.03, 4.57±0.02, 5.21±0.03 unit/mg protein, respectively. Thus, treatment of LPS-stimulated cells with oyster shell extract enhanced anti-oxidant enzyme activities that may be helpful in attenuating inflammation.

NO production
=============

NO is a pluripotent signaling molecule synthesized by a family of nitric oxide synthase isoforms (NOS) found in most tissues ([@b30-pnf_2013_v18n1_23],[@b31-pnf_2013_v18n1_23]). NO has beneficial roles in host defense system against tumor cells, viral replication and other factors. However, over production of NO causes various inflammatory diseases ([@b32-pnf_2013_v18n1_23]). Namely, NO is an important mediator and regulator of inflammatory responses. In an inflammatory response, the overproduction of NO reacts with superoxide creating cytotoxicity and tissue damage in an organism ([@b33-pnf_2013_v18n1_23]). The effect of oyster shell extract on NO inhibition was determined by treating the Raw 264.7 cells of LPS stimulation ([Fig. 3](#f3-pnf_2013_v18n1_23){ref-type="fig"}). LPS significantly increased NO production in Raw 264.7 cells. The level of NO production induced by LPS decreased significantly (p\<0.05) in a dose-dependent manner when treated with different concentrations of oyster shell extract; with 10, 25, 50 and 100 μg/mL of oyster shell extract, NO production was 125.12%, 120.03%, 110.21%, 101.67%, respectively, compared with LPS treatment alone to 196.67%. In this study, oyster shell extract effectively decreased NO production, indicating oyster shell extract might be useful to suppress the inflammatory process.

Effects of oyster shell extract on TNF-α, IL-1β and IL-6 expressions
--------------------------------------------------------------------

Macrophages, important components in the human immune defense system, respond actively to inflammation by releasing pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6; high levels of these cytokines can cause systemic complications ([@b34-pnf_2013_v18n1_23]). TNF-α is a pleiotropic inflammatory cytokine and can stimulate the production or expression of IL-1β and IL-6 ([@b35-pnf_2013_v18n1_23]). IL-6 is a pivotal pro-inflammatory cytokine synthesized mainly by macrophages and plays a role in the acute-phase inflammation response ([@b36-pnf_2013_v18n1_23]). IL-1β is also considered to be another pivotal pro-inflammatory cytokine ([@b37-pnf_2013_v18n1_23]). LPS stimulation of Raw 264.7 cells increased the production of TNF-α, IL-1β, and IL-6. As shown in [Fig. 4](#f4-pnf_2013_v18n1_23){ref-type="fig"}, after treatment with oyster shell extract, these increases were significantly reduced (p\<0.05) in a dose-dependent manner.This result indicates that oyster shell extract can attenuate the production of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6.

Effects of oyster shell extract on NF-κB, iNOS and COX-2 expressions
--------------------------------------------------------------------

As shown in [Fig. 5](#f5-pnf_2013_v18n1_23){ref-type="fig"}, NF-κB was increased in LPS-stimulated Raw 264.7 cells, and this increase was significantly reduced (p\<0.05) by treatment with oyster shell extract in a concentration-dependent manner. Activation of the NF-κB family plays a central role in inflammation through its ability to induce transcription of pro-inflammatory genes ([@b38-pnf_2013_v18n1_23]). NF-κB is one of the principal factors for the expression of COX-2 and iNOS as mediated by the LPS or pro-inflammatory cytokines ([@b39-pnf_2013_v18n1_23]). LPS stimulation of the Raw 264.7 cells strongly upregulated the iNOS and COX-2 protein expression levels. However, when oyster shell extract was added to the Raw 264.7 cells, the iNOS and COX-2 activities were significantly suppressed (p\< 0.05) than that treated with the LPS only ([Fig. 5](#f5-pnf_2013_v18n1_23){ref-type="fig"}). Usually, activated inflammatory cells produce high quantities of NO, which in turn produce iNOS. NO is necessary for maintaining prolonged COX-2 gene expression, a central mediator in inflammation ([@b40-pnf_2013_v18n1_23],[@b41-pnf_2013_v18n1_23]). Both iNOS and COX-2 are inducible forms of enzymes up-regulated in response to inflammation challenge. Expression of iNOS and COX-2 can be regulated by the activation of NF-κB ([@b42-pnf_2013_v18n1_23]). In this study, the production of NF-κB, iNOS and COX-2 were inhibited by oyster shell extract.

In conclusion, oyster shell extract significantly decreased intracellular ROS levels and increased anti-oxidant enzyme activities. Also, oyster shell extract blocked NO production and the expressions of TNF-α, IL-1β, IL-6, NF-κB, iNOS and COX-2 in LPS stimulated Raw 264.7 cells. Together, these results suggest oyster shell extract could be useful as a natural anti-oxidant and anti-inflammatory resource.

Oyster shell extract contains an abundant amount of calcium carbonate. Therefore, we suggest that calcium carbonate in oyster shell could be effective for inhibition of the inflammation process. However, further studies are needed to identify which ingredients in oyster shell extract inhibit the inflammation.

This research was a part of the project titled "Osteoarthritis health functional food development that use oyster shell" funded by the Ministry of Land, Transport and Maritime Affairs, Korea (KIMT-2012-D11110411H3900 00111).

![Effect of oyster shell extract on cytotoxicity in Raw 264.7 cells. Cells in 96-well plates (2×10^4^ cells/well) were incubated with and without indicated concentrations of oyster shell extract for 20 h. Each value is expressed as mean±SD in triplicate experiment.](pnf_2013_v18n1_23f1){#f1-pnf_2013_v18n1_23}

![Effect of oyster shell extract on intracellular ROS levels in LPS-stimulated Raw 264.7 cells. Cells (2×10^4^ cells/well) in 96-well plates were first incubated with and without indicated concentrations of oyster shell extract for 2 h, and then incubated with LPS (1 μg/mL) for 20 h. Untreated is negative control without LPS treatment. Each value is expressed as mean± SD in triplicate experiments. Values with different alphabets are significantly different at p\<0.05 as analyzed by Duncan's multiple range test. OSE: Oyster shell extract.](pnf_2013_v18n1_23f2){#f2-pnf_2013_v18n1_23}

![Effects of oyster shell extract on NO levels in LPS-stimulated Raw 264.7 cells. Cells (2×10^4^ cells/well) in 96-well plates were first incubated with and without indicated concentrations of oyster shell extract for 2 h, and then incubated with LPS (1 μg/mL) for 20 h. Untreated is negative control without LPS treatment. Each value is expressed as mean±SD in triplicate experiments. Values with different alphabets are significantly different at p\<0.05 as analyzed by Duncan's multiple range test. OSE: Oyster shell extract.](pnf_2013_v18n1_23f3){#f3-pnf_2013_v18n1_23}

![Inhibitory effects of oyster shell extract on TNF-α, IL-1β and IL-6 production in LPS-stimulated Raw 264.7 cells. Equal amounts of cell lysates (30 μg) were subjected to electrophoresis and analysed for TNF-α, IL-1β and IL-6 production by Western blot. Raw 264.7 cells were preincubated with LPS (1 μg/mL) for 20 h, and then incubated without or with indicated concentrations of oyster shell extract for 20 h. Each value is expressed as mean±SD (n=3) and values with different alphabets are significantly different at p\<0.05 as analyzed by Duncan's multiple range test. OSE: Oyster shell extract.](pnf_2013_v18n1_23f4){#f4-pnf_2013_v18n1_23}

![Inhibitory effects of oyster shell extract on NF-κB, iNOS and COX-2 production in LPS-stimulated Raw 264.7 cells. Equal amounts of cell lysates (30 μg) were subjected to electrophoresis and analysed for NF-κB, iNOS and COX-2 production by Western blot. Raw 264.7 cells were preincubated with LPS (1 μg/mL) for 20 h, and then incubated with or without indicated concentrations of oyster shell extract for 20 h. Each value is expressed as mean±SD (n=3) and values with different alphabets are significantly different at p\<0.05 as analyzed by Duncan's multiple range test. OSE: Oyster shell extract.](pnf_2013_v18n1_23f5){#f5-pnf_2013_v18n1_23}

###### 

Effects of oyster shell extract on antioxidant enzyme activities in LPS-stimulated Raw 264.7 cells

                                 Untreated       Oyster shell extract (μg/mL)+LPS (1 μg/mL)                                                   
  ------------------------------ --------------- -------------------------------------------- --------------- --------------- --------------- ----------------
  SOD (μM/mg protein/min)        69.37±3.61^a^   26.09±2.55^e^                                45.83±2.56^d^   51.14±0.94^c^   63.89±2.63^b^   65.74±1.14^ab^
  Catalase (μM/mg protein/min)   1.66±0.04^a^    1.24±0.01^d^                                 1.56±0.01^c^    1.59±0.01^bc^   1.62±0.02^ab^   1.63±0.03^ab^
  GSH-px (unit/mg protein)       4.26±0.01^c^    2.71±0.04^e^                                 3.41±0.04^d^    4.25±0.03^c^    4.57±0.02^b^    5.21±0.03^a^

Cells (2×10^4^ cells/well) in 96-well plates were first incubated with or without indicated concentrations of oyster shell extract for 2 h and then incubated with LPS (1 μg/mL) for 20 h. Untreated is negative control without LPS treatment. Values with different alphabets are significantly different at p\<0.05 as analyzed by Duncan's multiple range test. SOD: Superoxide dismutase, GSH-px: Glutathione peroxidase.
